Oct 13 (Reuters) – WCG Clinical Inc, a clinical trial solutions company backed by Singapore’s sovereign wealth fund GIC, on Wednesday filed to withdraw its initial public offering in the United States. (Reporting by Niket Nishant in Bengaluru; Editing by Shailesh Kuber)

Read More